Tag Archives: Over

Pfizer Japan recalls high blood pressure drug over cancer-causing impurity

FILE PHOTO – The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann/File Photo TOKYO (Reuters) – The Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressure which was found to contain a carcinogenic substance in its active ingredient valsartan,… Read More »

Call for more transparency over ‘add-on’ fertility treatments

Many add-ons are available – but do they work?Phanie / Alamy By New Scientist staff and Press Association Clinics offering fertility treatment must be more transparent about the effectiveness and costs of “optional extras”, the UK’s fertility regulator has said. The Human Fertilisation and Embryology Authority says there is “no conclusive evidence” that any so-called… Read More »

As renewed debate over health care reform begins to simmer in Washington, can journalists give the topic the attention it needs?

Dec. 14th’s lower court ruling that the Affordable Care Act (ACA) is unconstitutional has again thrust health care back on the national agenda. It also gives journalists a chance to redeem themselves from what I have argued has been poor news coverage that helped fuel the public backlash against the law from the beginning. A lot… Read More »